Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis

Abstract

EPA-FFA has chemopreventative efficacy in FAP, to a degree similar to that previously observed with selective cyclo-oxygenase-2 inhibitors. EPA holds promise as a colorectal cancer chemoprevention agent with a favourable safety profile.